Ablative Therapies for Colorectal Polyps and Malignancy

by Jacqueline Oxenberg, Steven N. Hochwald, Steven Nurkin
Published 2014-01-01

Evolving Ablative Therapies for Hepatic Malignancy

by Smit Singla, Steven N. Hochwald, Boris Kuvshinoff
Published 2014-01-01

Ablative Therapy for Esophageal Dysplasia and Early Malignancy: Focus on RFA

by Rebecca Tuttle, Steven J. Nurkin, Steven N. Hochwald
Published 2014-01-01

Glucose Drives Growth Factor–Independent Esophageal Cancer Proliferation via Phosphohistidine–Focal Adhesion Kinase SignalingSummary

by Jianliang Zhang, Irwin H. Gelman, Eriko Katsuta, Yuanzi Liang, Xue Wang, Jun Li, Jun Qu, Li Yan, Kazuaki Takabe, Steven N. Hochwald
Published 2019-01-01

Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center

by Shruti G. Dighe, Li Yan, Sarbajit Mukherjee, Cailey S. McGillicuddy, Karen L. Hulme, Steven N. Hochwald, Saikrishna Yendamuri, Andrew J. Bain, Kevin T. Robillard, Kirsten B. Moysich, Christine B. Ambrosone, Amy E. Millen, Matthew F. Buas
Published 2021-09-01

Isoform-specific upregulation of palladin in human and murine pancreas tumors.

by Silvia M Goicoechea, Brian Bednarski, Christianna Stack, David W Cowan, Keith Volmar, Leigh Thorne, Edna Cukierman, Anil K Rustgi, Teresa Brentnall, Rosa F Hwang, Christopher A G McCulloch, Jen Jen Yeh, David J Bentrem, Steven N Hochwald, Sunil R Hingorani, Hong Jin Kim, Carol A Otey
Published 2010-04-01